Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Grifols SA

GRFS
7,155
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 12:19:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
31/5/202422:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/4/202422:42PRNUSGrifols 2023 Annual Report on Form 20-F filed with the SEC
18/4/202415:30GLOBEGrifols Celebrates 50 Years of Manufacturing Life-Changing..
15/4/202413:06IHMARKETNEWSSamsung Surpasses Apple in Q1 Smartphone Market; Salesforce..
04/4/202410:00GLOBEGrifols Procleix ArboPlex Assay® Receives CE Mark, the First..
22/3/202414:07IHMARKETNEWSFedEx Soars 13% with Profits Above Forecasts, Nike Hit by..
08/3/202412:19IHMARKETNEWSCNOOC Oil Field Discovery in South China Sea, Grifols Surges..
14/2/202409:16GLOBEGrifols announces positive topline phase 3 fibrinogen..
26/1/202423:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/1/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
10/1/202419:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202412:21IHMARKETNEWSWall Street Highlights: Tesla Launches Restyled Model 3,..
09/1/202420:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202414:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202315:59DJNGrifols Shares Rise on $1.76 Billion Sale of 20% Stake in..
29/12/202315:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202315:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202311:00PRNUSGrifols launches new solution to facilitate pre-transfusion..
15/11/202314:00GLOBEGrifols Completes Cohort 1 in Clinical Study of Alpha-1 15%,..
06/11/202314:00GLOBEGigaGen Presents IND-Enabling Data and Phase 1 Trial..
02/11/202318:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202300:30GLOBEAraclon Biotech Presents Positive Final Results from Phase 2..
20/10/202314:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/10/202314:00GLOBEGigaGen Granted Expansion of Contract with US Department of..
28/9/202314:00GLOBEGigaGen Partners with the National Cancer Institute to..
01/8/202314:00GLOBEGrifols Accelerates Healthcare Innovation with Google..
27/7/202317:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/7/202314:15GLOBEGrifols Achieves Positive Topline Results From Phase 4 Study..
18/7/202314:00GLOBEGrifols Completes Enrollment in Phase 3 Study of Long-term..
13/7/202314:00GLOBEGrifols Meets Enrollment Target in Phase 3 Study of Two Dose..
15/6/202301:34DJNADRs End Higher, Grifols, Victrex Trade Actively
14/6/202312:44DJNGrifols Shares Rise on Potential Sale of Shanghai RAAS Stock..
Apertura: Min: Max:
Chiusura: 7,155

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network